Use Of Ventricular Enlargement Rate In Intravenous Immunoglobulin Treatment Of Alzheimer's Disease

Details for Australian Patent Application No. 2012227191 (hide)

Owner Baxter Healthcare S.A. Baxter International Inc.

Inventors Relkin, Norman R.

Agent Cullens

Pub. Number AU-A-2012227191

Parent 2011240556

Filing date 19 September 2012

Wipo publication date 11 October 2012

International Classifications

A61B 5/05 Measuring for diagnostic purposes - Measuring for diagnosis by means of electric currents or magnetic fields

Event Publications

4 October 2012 Complete Application Filed

11 October 2012 Application Open to Public Inspection

  Published as AU-A-2012227191

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012227192-Improved Connecting Method

2012227190-Control of an Adaptive Feedback Cancellation System Based on Probe Signal Injection